⌘K

Login Start Free

Home/Companies/COAG

H

COAG//CIK 0002114044

Hemab Therapeutics Holdings, Inc.

SIC 2836Biological Products, (No Diagnostic Substances)operating

Exchange

Nasdaq

Entity type

operating

Fiscal year end

Dec 31

Headquarters

DE

Market Data

Sep 24, 9:30 AM ET

$35.72−$10.95 (−23.46%)

COAG · Last trade

Prev Close

$46.67

Range (30d)

$35.72 – $49.65

Recent Filings

10 items

8-K
Hemab Therapeutics Holdings, Inc.
Sep 24, 4:03 PM ET·0001193125-26-401010
145.5 KB
SCHEDULE 13G
Hemab Therapeutics Holdings, Inc.
Aug 14, 5:05 PM ET·0001388325-26-000046
6.9 KB
SCHEDULE 13G
Hemab Therapeutics Holdings, Inc.
Aug 14, 9:01 AM ET·0000902664-26-003462
17.9 KB
SCHEDULE 13G
Hemab Therapeutics Holdings, Inc.
Aug 12, 10:28 AM ET·0001562230-26-000124
7.6 KB
10-Q
Hemab Therapeutics Holdings, Inc.
Aug 11, 4:00 PM ET·0001193125-26-344533
10.3 MB
8-K
Hemab Therapeutics Holdings, Inc.
Aug 11, 7:11 AM ET·0001193125-26-343421
251.3 KB
SCHEDULE 13G
Hemab Therapeutics Holdings, Inc.
Aug 7, 9:31 AM ET·0002005369-26-000041
25.2 KB
SCHEDULE 13G
Hemab Therapeutics Holdings, Inc.
Aug 6, 10:28 AM ET·0000315066-26-002021
11.6 KB
SCHEDULE 13G
Hemab Therapeutics Holdings, Inc.
Aug 5, 10:38 AM ET·0001104659-26-090835
32.7 KB
10-Q
Hemab Therapeutics Holdings, Inc.
May 21, 4:02 PM ET·0001193125-26-234386
6.7 MB

Insiders

10

Tickers

COAGNasdaq→

Addresses

business
101 MAIN STREET SUITE 1220
CAMBRIDGE, MA, 02142
mailing
101 MAIN STREET SUITE 1220
CAMBRIDGE, MA, 02142

Related Biological Products, (No Diagnostic Substances) Companies

IVORY CAPITAL CORP

AERIE PHARMACEUTICALS INC

Cellular Biomedicine Group, Inc.

Kymera Therapeutics, Inc.

KYMR

Tourmaline Bio, Inc.

TRML

NKGen Biotech, Inc.

View all Biological Products, (No Diagnostic Substances) companies →